5-(Trifluoromethyl)-1,3-oxazole-4-carboxylic acid, 95%, 250mg

3-Methoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine, 95.0%, 250mg

tert-Butyl (2-methoxyphenyl)carbamate, 95.0%, 25g

3,3'-Bis(trifluoromethyl)benzophenone, 97.0%, 1g

4-[(3-nitro-1H-pyrazol-1-yl)methyl]benzonitrile, 95.0%, 2g

tert-Butyl (4-aminophenyl)carbamate, 99.00%, 10g

4-Bromopyrazolo[1,5-a]pyridine-3-carbonitrile, 97.0%, 5g

2,4-Dichloro-6-(propan-2-yl)pyrimidine, 98+%, 100mg

5-Bromo-2-benzyloxy-6-methylpyridine, 95.0%, 100g

N-(4-(Trifluoromethyl)benzyl)ethanamine, 95.0%, 1g

HPLC column NUCLEODUR® NH2-RP 5 µm, 250 mm, 4 mm, 1 Piece(s)

(4-Fmoc-amino-tetrahydropyran-4-yl)acetic acid, 97.0%, 250mg

(R)-2-((5-Amino-7-chloro-3H-imidazo[4,5-b]pyridin-3-yl)methyl)-4,4-diethoxybutyl acetate, 96%, 50mg